PartsTable
Technical Data Sheet
Download PDF

NDC63323-0269-65 — PROPOFOL INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC63323-0269-65: PROPOFOL INJECTION.

The PROPOFOL INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, supplementary_features: REPLACEMENT FOR NSN 6505-01-380-5889, total_primary_container_quantity: 10, primary_container_content_quantity: 100.000 MILLILITERS, active_medicament_medicinal_strength: 10.000 MILLIGRAMS PROPOFOL EQUIVALENT PER MILLILITER. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-434-8619, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC63323-0269-65
NSN: 6505-01-434-8619
FSC: 6505 — Drugs and Biologicals
CAGE: 57KZ6 — FRESENIUS KABI, LLC (USA)
SPECIFICATIONS
administrationINTRAVENOUS
special_featuresALSO CONTAINS 0.005 PCT DISODIUM EDETATE. STORE AT USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. SHAKE WELL BEFORE USE.
primary_container_typeVIAL
supplementary_featuresREPLACEMENT FOR NSN 6505-01-380-5889
total_primary_container_quantity10
primary_container_content_quantity100.000 MILLILITERS
active_medicament_medicinal_strength10.000 MILLIGRAMS PROPOFOL EQUIVALENT PER MILLILITER
part_name_assigned_by_controlling_agencyPROPOFOL INJECTION 10MG/ML 100ML VIAL 10S
NSN6505-01-434-8619
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available PROPOFOL INJECTION TITLE COMPONENT PN NDC63323-0269-65 MFR PROPOFOL INJECTION
KEY FEATURES
•
ADMINISTRATION: INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
•
SUPPLEMENTARY FEATURES: REPLACEMENT FOR NSN 6505-01-380-5889
•
PRIMARY CONTAINER TYPE: VIAL
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS PROPOFOL EQUIVALENT PER MILLILITER
•
TOTAL PRIMARY CONTAINER QUANTITY: 10
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY100.000 MILLILITERS
SUPPLEMENTARY FEATURESREPLACEMENT FOR NSN 6505-01-380-5889
PRIMARY CONTAINER TYPEVIAL
SPECIAL FEATURESALSO CONTAINS 0.005 PCT DISODIUM EDETATE. STORE AT USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. SHAKE WELL BEFORE USE.
PART NAME ASSIGNED BY CONTROLLING AGENCYPROPOFOL INJECTION 10MG/ML 100ML VIAL 10S
ACTIVE MEDICAMENT MEDICINAL STRENGTH10.000 MILLIGRAMS PROPOFOL EQUIVALENT PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY10
SUBSTITUTES & CROSS-REFERENCES 1
DIPRIVANReference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
HAZMAT per U.S. Government catalogShelf-life managedNo demilitarization required
Ready to buy NDC63323-0269-65?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC63323-0269-65?
NDC63323-0269-65 is a PROPOFOL INJECTION.
What parts can replace NDC63323-0269-65?
There is 1 known substitute for NDC63323-0269-65: DIPRIVAN. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC63323-0269-65?
NDC63323-0269-65 is cataloged in the U.S. Government catalog under NSN 6505-01-434-8619. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC63323-0269-65